Roche and Illumina
Anyone following this? Looks like a hostile takeover strategy case study. It covers staggered boards, proxy advisory firms, and poison pills. Really interesting. Is it gonna happen? If you were the adviser to Roche or Illumina, what would tell them?
Out of curiosity, how are hedgies and arbs playing this?
Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…
[quote=SECfinance]Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…]
Look at their previous 2 major acquisitions. Both Ventana and Genentech took more than 6 months to buy. Do you really think it's over?
I think it's over for now. That's not to say Roche won't come in in the future and try again but this attempt is done.
Et voluptatum neque aperiam. Quis quis id nam cumque dolorem cupiditate. Qui voluptatem harum et animi perferendis officia. Quaerat nostrum aut eius at asperiores necessitatibus atque.
Error nulla ut odio impedit dicta perferendis. Cupiditate soluta vel facere eum. Voluptatibus rem quam repellendus temporibus reiciendis voluptatum.
Minima id voluptatum asperiores maxime sint ullam enim. Qui eos dignissimos commodi delectus fuga. Ut ipsa voluptatem et aut sit et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...